First Mercantile Trust’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$117K Sell
2,162
-758
-26% -$35.6K 0.02% 605
2021
Q2
$98K Sell
2,920
-594
-17% -$16.3K 0.01% 691
2021
Q1
$72K Buy
+3,514
New +$80.7K 0.01% 739
2017
Q3
Sell
-666
Closed -$25K 794
2017
Q2
$25K Sell
666
-215
-24% -$9.51K ﹤0.01% 804
2017
Q1
$48K Sell
881
-66
-7% -$3.44K 0.01% 791
2016
Q4
$50K Sell
947
-93
-9% -$5.29K 0.01% 798
2016
Q3
$63K Sell
1,040
-116
-10% -$7.22K 0.01% 781
2016
Q2
$76K Sell
1,156
-83
-7% -$5.27K 0.01% 796
2016
Q1
$70K Buy
+1,239
New +$139K 0.01% 800
2015
Q2
Sell
-927
Closed -$388K 988
2015
Q1
$388K Sell
927
-90
-9% -$32.2K 0.03% 579
2014
Q4
$278K Buy
+1,017
New +$253K 0.02% 630
2014
Q2
Sell
-593
Closed -$157K 1211
2014
Q1
$157K Sell
593
-1,291
-69% -$494K 0.01% 851
2013
Q4
$684K Sell
1,884
-191
-9% -$73.6K 0.05% 488
2013
Q3
$1.1M Buy
2,075
+648
+45% +$222K 0.09% 334
2013
Q2
$334K Buy
+1,427
New +$281K 0.03% 635

Other funds holding CLDX